Treatment of Cystic Fibrosis: From Gene- to Cell-Based Therapies
Prognosis of patients with cystic fibrosis (CF) varies extensively despite recent advances in targeted therapies that improve CF transmembrane conductance regulator (CFTR) function. Despite being a multi-organ disease, extensive lung tissue destruction remains the major cause of morbidity and mortal...
Saved in:
Main Authors: | Katelin M. Allan (Author), Nigel Farrow (Author), Martin Donnelley (Author), Adam Jaffe (Author), Shafagh A. Waters (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
S945L-CFTR molecular dynamics, functional characterization and tezacaftor/ivacaftor efficacy in vivo and in vitro in matched pediatric patient-derived cell models
by: Katelin M. Allan, et al.
Published: (2022) -
Breaching the Delivery Barrier: Chemical and Physical Airway Epithelium Disruption Strategies for Enhancing Lentiviral-Mediated Gene Therapy
by: Alexandra McCarron, et al.
Published: (2021) -
Gene Therapy for Cystic Fibrosis Lung Disease: Overcoming the Barriers to Translation to the Clinic
by: Martin Donnelley, et al.
Published: (2018) -
Human Primary Epithelial Cell Models: Promising Tools in the Era of Cystic Fibrosis Personalized Medicine
by: Nikhil T. Awatade, et al.
Published: (2018) -
Single-Dose Lentiviral Mediated Gene Therapy Recovers CFTR Function in Cystic Fibrosis Knockout Rats
by: Nicole Reyne, et al.
Published: (2021)